Synthetic bone substitutes

Current Opinion in Orthopaedics

Volumn 11, Issue 5, 2000, Pages 383-390

  Lu, Lichun ^a   Currier, Bradford L ^a   Yaszemski, Michael J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CALCIUM PHOSPHATE; COPOLYMER; CYTOKINE; FIBRONECTIN; GROWTH FACTOR; MACROGOL; OSTEOCLAST DIFFERENTIATION FACTOR; PLASMA PROTEIN; PLASMID DNA; POLITEF; POLY(METHYL METHACRYLATE); POLYANHYDRIDE; POLYGLACTIN; POLYLACTIC ACID; POLYMER; POLYPROPYLENE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ARTICLE; BIOENGINEERING; BONE DEFECT; BONE GRAFT; BONE PROSTHESIS; BONE REGENERATION; BONE TRANSPLANTATION; CELL DIFFERENTIATION; CERAMICS; HUMAN; NONHUMAN; PRIORITY JOURNAL;

EID: 0033799311     PISSN: 10419918     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001433-200010000-00010     Document Type: Article

References (63)

1. Morbidity at bone graft donor sites
2. The ingrowth of new bone tissue and initial mechanical properties of a degrading polymeric composite scaffold
3. In vitro degradation of a poly-(propylene fumarate)-based composite material
4. In vitro degradation of a poly(propylene fumarate)/B-tricalcium phosphate composite orthopaedic scaffold
5. In vivo degradation of a poly(propylene fumarate)/B-tricalcium phosphate injectable composite scaffold
6. Crosslinking chracteristics of an injectable poly(propylene fumarate)/B-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement
7. Synthetic biodegradable polymers for orthopaedic applications
8. Guided tissue fabrication from periosteum using preformed biodegradable polymer scaffolds
9. Tissue engineering of bone in the craniofacial complex
10. Bioactive ceramics: The effect of surface reactivity on bone formation and bone cell function
11. Resorbable bioceramics based on stabilized calcium phosphates. Part I: Rational design, sample preparation and material characterization
12. Fabrication, characterization and evaluation of bioceramic hollow microspheres used as microcarriers for 3·D bone tissue formation in rotating bioreactors
13. Histomorphometric analysis of a half hydroxyapatite-coated implant in humans: A pilot study
14. Implantation of octacalcium phosphate (OCP) in rat skull defects enhances bone repair
15. Volume effect on biological properties of a calcium phosphate hydraulic cement: Experimental study in sheep
16. Kinetic study of bone ingrowth and ceramic resorption associated with the implantation of different injectable calcium-phosphate bone substitutes
17. Effect of bioactive filler content on mechanical properties and osteoconductivity of bioactive bone cement
18. Short-term effects of mineral particle sizes on cellular degradation activity after implantation of injectable calcium phosphate biomaterials and the consequences for bone substitution
19. Effect of serum proteins on osteoblast adhesion to surface-modified bioactive glass and hydroxyapatite
20. Reconstruction of bone using calcium phosphate bone cements: A critical review
21. Guided tissue regeneration with a bioabsorbable polylactic acid membrane in gingival recessions. A histometric study in dogs
22. Polylactide bioabsorbable polymers for guided tissue regeneration
23. Osseointegration of preformed polymethylmethacrylate craniofacial prostheses coated with bone marrow-impregnated poly (DL-lactic-co-glycolic acid) foam
24. Influence of sterilization on injectable bone biomaterials
25. Transdermal photopolymerization for minimally invasive implantation
26. Crosslinked polyanhydrides for use in orthopedic applications: Degradation behavior and mechanics
27. Effect of a poly(propylene fumarate) foaming cement on the healing of bone defects
28. Bioabsorbable suture anchor (copolymer 85/15 D,L lactide/glycolide) implanted in bone: Correlation of physical/mechanical properties, magnetic resonance imaging, and histological response
29. Bone graft materials. An overview of the basic science
30. Bone morphogenetic proteins: An update on basic biology and clinical relevance
31. Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling
32. Tissue-engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats
33. Bone regeneration produced in rat femur defects by polymer capsules containing recombinant human bone morphogenetic protein-2
34. Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer
35. Evaluation of human recombinant bone morphogenetic protein-2-loaded tricalcium phosphate implants in rabbits' bone defects
36. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2
37. Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine. A comparison of three dosages and two carriers
38. Effects of TGFB on bone ingrowth in the presence of polyethylene particles
39. Skull bone regeneration in primates in response to basic fibroblast growth factor
40. Human bone morphogenetic protein allografting for reconstruction of femoral nonunion
41. Growth factors regulate expression of osteoblast-associated genes
42. Treatment of peri-implant defects with combination growth factor cement
43. Characterization of matrix-induced osteogenesis in rat calvarial bone defects: I. Differences in the cellular response to demineralized bone matrix implanted in calvarial defects and in subcutaneous sites
44. Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices
45. Carrier systems for bone morphogenetic proteins
46. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery
47. New synthetic absorbable polymers as BMP carriers: Plastic properties of poly-D,L-lactic acid-polyethylene glycol block copolymers
48. DNA delivery from polymer matrices for tissue engineering
49. Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration
50. Impact of nicotine on bone healing
51. Principles of tissue engineered regeneration of skeletal tissues
52. High variability in rabbit bone marrow-derived mesenchymal cell preparations
53. Effect of age and sampling site on the chondro-osteogenic potential of rabbit marrow-derived mesenchymal progenitor cells
54. Marrow-derived progenitor cell injections enhance new bone formation during distraction
55. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse
56. Establishing an immortalized human osteoprecursor cell line: OPC1
57. Modulation of marrow stromal cell function using poly(D,L-lactic acid)-block-poly(ethylene glycol)-monomethyl ether surfaces
58. The effect of poly-L-lactic acid with parallel surface micro groove on osteoblast-like cells in vitro
59. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, B-glycerol-phosphate, and L-ascorbic acid
60. Differential display of human marrow stromal cells reveals unique mRNA expression patterns in response to dexamethasone
61. Enhancement of osteogenesis in vitro and in vivo by a novel osteoblast differentiation promoting compound, TAK-778
62. Effect of osteoblast culture conditions on the structure of poly(DL-lactic-co-glycolic acid) foam scaffolds
63. Coculture system to assess biocompatibility of candidate orthopaedic materials